Breaking News Instant updates and real-time market news.

08:45
09/25/20
09/25
08:45
09/25/20
08:45

U.S. equity futures are mostly lower

U.S. equity futures are mostly lower, having given up overnight gains. The Dow mini is down -0.5%, the S&P 500 mini is off -0.4% and the NASDAQ is marginally firmer with a 0.04% increase. The usual suspects are to blame for stock market weakness -- the surge in virus infections in Europe that has prompted a fresh round of restrictions continues to unsettle the market. Additionally, there is ongoing concern over the U.S. elections and disappointment that Washington has not delivered more stimulus. European bourses are weaker, with the Euro Stoxx down -1.4%, Germany's DAX off -1.5% and France's CAC 40 dropping -1.5%. The UK'S FTSE 100 has slipped -0.3%. Japanese shares and most Asian markets closed firmer, though China's CSI 300 slipped -0.3%.

TODAY'S FREE FLY STORIES

Hot Stocks
BioCryst announces publication of data from first 24 weeks of APeX-2 trial » 07:26
10/22/20
10/22
07:26
10/22/20
07:26
BCRX

BioCryst

$3.60 /

+0.085 (+2.42%)

BioCryst Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

09/30/20 Piper Sandler
Piper says BioCryst's early high dose 9930 data 'impressive'
09/29/20 JPMorgan
BioCryst resumed with an Overweight at JPMorgan
06/26/20 JMP Securities
BioCryst price target raised to $11 from $10 at JMP Securities
06/16/20 BTIG
BioCryst initiated with a Neutral at BTIG
BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

  • 28
    May
  • 14
    Nov
BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

Recommendations
Crispr Therapeutics price target raised to $120 from $110 at Canaccord » 07:25
10/22/20
10/22
07:25
10/22/20
07:25
CRSP

Crispr Therapeutics

$92.25 /

-14.68 (-13.73%)

Canaccord analyst Arlinda…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$92.25 /

-14.68 (-13.73%)

CRSP Crispr Therapeutics
$92.25 /

-14.68 (-13.73%)

06:27 Today Citi
Crispr Therapeutics price target raised to $47 from $31 at Citi
10/21/20 Raymond James
First CAR-T data for Crispr's CTX110 'not good,' says Raymond James
10/21/20 Stifel
Crispr Therapeutics price target raised to $93 from $75 at Stifel
10/21/20 Roth Capital
Crispr Therapeutics price target raised to $115 from $105 at Roth Capital
CRSP Crispr Therapeutics
$92.25 /

-14.68 (-13.73%)

  • 01
    Jul
  • 21
    Nov
CRSP Crispr Therapeutics
$92.25 /

-14.68 (-13.73%)

Recommendations
Teradyne price target raised to $80 from $73 at UBS » 07:25
10/22/20
10/22
07:25
10/22/20
07:25
TER

Teradyne

$92.06 /

+4.09 (+4.65%)

UBS analyst Timothy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TER Teradyne
$92.06 /

+4.09 (+4.65%)

TER Teradyne
$92.06 /

+4.09 (+4.65%)

07:15 Today Deutsche Bank
Teradyne price target raised to $110 from $95 at Deutsche Bank
06:52 Today Baird
Teradyne price target raised to $105 from $90 at Baird
05:25 Today Susquehanna
Teradyne upgraded to Neutral from Negative at Susquehanna
10/09/20 Stifel
Teradyne upgraded to Buy on improving growth prospects at Stifel
TER Teradyne
$92.06 /

+4.09 (+4.65%)

TER Teradyne
$92.06 /

+4.09 (+4.65%)

TER Teradyne
$92.06 /

+4.09 (+4.65%)

Conference/Events
Actinium Pharmaceuticals to host conference call » 07:25
10/22/20
10/22
07:25
10/22/20
07:25
ATNM

Actinium Pharmaceuticals

$11.84 /

+0.89 (+8.13%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATNM Actinium Pharmaceuticals
$11.84 /

+0.89 (+8.13%)

ATNM Actinium Pharmaceuticals
$11.84 /

+0.89 (+8.13%)

09/21/20 JonesTrading
Actinium Pharmaceuticals transferred with a Buy at JonesTrading
06/04/20 H.C. Wainwright
Actinium Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/17/20 JonesTrading
Key Actinium questions could be answered sooner than expected, says JonesTrading
  • 17
    Jun
  • 22
    Apr
ATNM Actinium Pharmaceuticals
$11.84 /

+0.89 (+8.13%)

Hot Stocks
Bio-Path Holdings receives notice of allowance for patent for prexigebersen » 07:24
10/22/20
10/22
07:24
10/22/20
07:24
BPTH

Bio-Path Holdings

$4.09 /

-0.01 (-0.24%)

Bio-Path Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BPTH Bio-Path Holdings
$4.09 /

-0.01 (-0.24%)

BPTH Bio-Path Holdings
$4.09 /

-0.01 (-0.24%)

08/17/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $12 from $18
08/17/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $12 from $18 at H.C. Wainwright
05/18/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $18 from $25 at H.C. Wainwright
BPTH Bio-Path Holdings
$4.09 /

-0.01 (-0.24%)

BPTH Bio-Path Holdings
$4.09 /

-0.01 (-0.24%)

Recommendations
Align Technology price target raised to $432 from $348 at Credit Suisse » 07:24
10/22/20
10/22
07:24
10/22/20
07:24
ALGN

Align Technology

$334.67 /

-0.38 (-0.11%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALGN Align Technology
$334.67 /

-0.38 (-0.11%)

ALGN Align Technology
$334.67 /

-0.38 (-0.11%)

06:44 Today Barclays
Align Technology price target raised to $400 from $300 at Barclays
06:43 Today Baird
Align Technology price target raised to $450 from $370 at Baird
04:58 Today Piper Sandler
Align Technology price target raised to $500 from $400 at Piper Sandler
10/15/20 Piper Sandler
Piper names Align Technology top pick, boosts target to $400 from $345
ALGN Align Technology
$334.67 /

-0.38 (-0.11%)

ALGN Align Technology
$334.67 /

-0.38 (-0.11%)

Hot Stocks
DSP Group announces support of TensorFlow Lite for Microcontrollers » 07:23
10/22/20
10/22
07:23
10/22/20
07:23
DSPG

DSP Group

$14.34 /

-0.08 (-0.55%)

DSP Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DSPG DSP Group
$14.34 /

-0.08 (-0.55%)

DSPG DSP Group
$14.34 /

-0.08 (-0.55%)

06/09/20 Roth Capital
DSP Group price target raised to $25 from $20 at Roth Capital
01/10/20 Lake Street
DSP Group named a favorite idea for 2020 at Lake Street
DSPG DSP Group
$14.34 /

-0.08 (-0.55%)

Recommendations
Biogen price target lowered to $350 from $359 at Credit Suisse » 07:23
10/22/20
10/22
07:23
10/22/20
07:23
BIIB

Biogen

$269.10 /

+1.6 (+0.60%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$269.10 /

+1.6 (+0.60%)

BIIB Biogen
$269.10 /

+1.6 (+0.60%)

06:46 Today Barclays
Biogen price target lowered to $265 from $275 at Barclays
10/21/20 Piper Sandler
Piper Sandler 'firmly' on the sidelines after Biogen's Q3 report
10/21/20 Evercore ISI
Biogen release includes several important pipeline updates, says Evercore ISI
10/19/20 RBC Capital
Biogen price target lowered to $268 from $281 at RBC Capital
BIIB Biogen
$269.10 /

+1.6 (+0.60%)

BIIB Biogen
$269.10 /

+1.6 (+0.60%)

BIIB Biogen
$269.10 /

+1.6 (+0.60%)

BIIB Biogen
$269.10 /

+1.6 (+0.60%)

BIIB Biogen
$269.10 /

+1.6 (+0.60%)

Hot Stocks
Plug Power develops new GenDrive products for European market » 07:23
10/22/20
10/22
07:23
10/22/20
07:23
PLUG

Plug Power

$14.87 /

-1.41 (-8.66%)

Plug Power has expanded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLUG Plug Power
$14.87 /

-1.41 (-8.66%)

PLUG Plug Power
$14.87 /

-1.41 (-8.66%)

09/28/20 Morgan Stanley
Morgan Stanley upgrades Plug Power to Overweight on rapid growth potential
09/28/20 Morgan Stanley
Plug Power upgraded to Overweight from Equal Weight at Morgan Stanley
09/25/20 B. Riley FBR
Plug Power remains on track to 2024 targets, says B. Riley FBR
09/25/20 Barclays
Plug Power price target raised to $13 from $12 at Barclays
PLUG Plug Power
$14.87 /

-1.41 (-8.66%)

  • 12
    Aug
  • 06
    Dec
PLUG Plug Power
$14.87 /

-1.41 (-8.66%)

PLUG Plug Power
$14.87 /

-1.41 (-8.66%)

PLUG Plug Power
$14.87 /

-1.41 (-8.66%)

Hot Stocks
Daqo New Energy comments on recent research report about forced labor » 07:23
10/22/20
10/22
07:23
10/22/20
07:23
DQ

Daqo New Energy

$199.17 /

-42.64 (-17.63%)

Daqo New Energy addressed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DQ Daqo New Energy
$199.17 /

-42.64 (-17.63%)

DQ Daqo New Energy
$199.17 /

-42.64 (-17.63%)

10/16/20 Roth Capital
Daqo New Energy price target raised to $220 from $150 at Roth Capital
08/19/20 Roth Capital
Daqo New Energy price target raised to $150 from $120 at Roth Capital
07/22/20 Roth Capital
Daqo shares should move higher with poly pricing, says Roth Capital
07/20/20 Roth Capital
Roth boosts Daqo target to $120 after polysilicon facility explosion reports
DQ Daqo New Energy
$199.17 /

-42.64 (-17.63%)

Earnings
NeuroMetrix reports Q3 revenue $2M vs. $2.1M last year » 07:22
10/22/20
10/22
07:22
10/22/20
07:22
NURO

NeuroMetrix

$1.65 /

-0.03 (-1.79%)

Reports net loss $0.3M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NURO NeuroMetrix
$1.65 /

-0.03 (-1.79%)

NURO NeuroMetrix
$1.65 /

-0.03 (-1.79%)

Recommendations
Icon price target raised to $235 from $230 at Credit Suisse » 07:21
10/22/20
10/22
07:21
10/22/20
07:21
ICLR

Icon

$202.96 /

-0.75 (-0.37%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ICLR Icon
$202.96 /

-0.75 (-0.37%)

ICLR Icon
$202.96 /

-0.75 (-0.37%)

07/27/20 SunTrust
SunTrust raises price targets on select late-stage CROs
07/27/20 Deutsche Bank
Icon price target raised to $170 from $135 at Deutsche Bank
07/27/20 Mizuho
Icon price target raised to $195 from $170 at Mizuho
07/24/20 BofA
Icon downgraded to Neutral from Buy at BofA
ICLR Icon
$202.96 /

-0.75 (-0.37%)

Earnings
Citrix sees FY21 EPS 6.20-$6.40, consensus $6.19 » 07:20
10/22/20
10/22
07:20
10/22/20
07:20
CTXS

Citrix

$136.50 /

-0.38 (-0.28%)

Sees FY 21 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTXS Citrix
$136.50 /

-0.38 (-0.28%)

CTXS Citrix
$136.50 /

-0.38 (-0.28%)

10/13/20 UBS
Citrix initiated with a Neutral at UBS
07/31/20 Stifel
Citrix disclosure points to $1B commitment, most likely to Azure, says Stifel
07/20/20
Fly Intel: Top five analyst upgrades
07/20/20 Barclays
Citrix upgraded to Overweight with $180 price target at Barclays
CTXS Citrix
$136.50 /

-0.38 (-0.28%)

CTXS Citrix
$136.50 /

-0.38 (-0.28%)

CTXS Citrix
$136.50 /

-0.38 (-0.28%)

Recommendations
Thermo Fisher price target raised to $488 from $432 at Credit Suisse » 07:19
10/22/20
10/22
07:19
10/22/20
07:19
TMO

Thermo Fisher

$468.79 /

+3.375 (+0.73%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TMO Thermo Fisher
$468.79 /

+3.375 (+0.73%)

TMO Thermo Fisher
$468.79 /

+3.375 (+0.73%)

06:45 Today Baird
Thermo Fisher price target raised to $512 from $481 at Baird
10/06/20 BofA
Qiagen resumed with Buy at BofA
10/05/20 JPMorgan
Thermo Fisher price target raised to $480 from $460 at JPMorgan
09/30/20
Fly Intel: Top five analyst initiationsNewPage
TMO Thermo Fisher
$468.79 /

+3.375 (+0.73%)

TMO Thermo Fisher
$468.79 /

+3.375 (+0.73%)

TMO Thermo Fisher
$468.79 /

+3.375 (+0.73%)

TMO Thermo Fisher
$468.79 /

+3.375 (+0.73%)

Hot Stocks
Nevakar announces FDA approval for ephedrine sulfate injection » 07:19
10/22/20
10/22
07:19
10/22/20
07:19
ENDP

Endo

$5.47 /

-0.33 (-5.69%)

Nevakar announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENDP Endo
$5.47 /

-0.33 (-5.69%)

ENDP Endo
$5.47 /

-0.33 (-5.69%)

10/20/20 H.C. Wainwright
BioSpecifics downgraded to Neutral from Buy at H.C. Wainwright
10/05/20 Piper Sandler
Piper reiterates Overweight on Endo after dermatologist survey
09/25/20 Raymond James
Endo deal could generate $50M-$75M in cash inflow, says Raymond James
07/27/20 Goldman Sachs
Endo initiated with a Sell at Goldman Sachs
ENDP Endo
$5.47 /

-0.33 (-5.69%)

ENDP Endo
$5.47 /

-0.33 (-5.69%)

ENDP Endo
$5.47 /

-0.33 (-5.69%)

ENDP Endo
$5.47 /

-0.33 (-5.69%)

Downgrade
Citi downgrades Aramark to Neutral with normalcy still year away » 07:19
10/22/20
10/22
07:19
10/22/20
07:19
ARMK

Aramark

$29.03 /

+0.18 (+0.62%)

Citi analyst James Ainley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARMK Aramark
$29.03 /

+0.18 (+0.62%)

ARMK Aramark
$29.03 /

+0.18 (+0.62%)

06:26 Today Citi
Aramark downgraded to Neutral from Buy at Citi
09/25/20 Oppenheimer
Aramark price target raised to $35 from $30 at Oppenheimer
09/09/20
Fly Intel: Top five analyst upgrades
09/08/20 Goldman Sachs
Aramark upgraded to Buy from Neutral at Goldman Sachs
ARMK Aramark
$29.03 /

+0.18 (+0.62%)

ARMK Aramark
$29.03 /

+0.18 (+0.62%)

ARMK Aramark
$29.03 /

+0.18 (+0.62%)

Recommendations
Lam Research price target raised to $424 from $376 at Goldman Sachs » 07:19
10/22/20
10/22
07:19
10/22/20
07:19
LRCX

Lam Research

$366.51 /

+2.66 (+0.73%)

, SMICY

SMIC

$5.41 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LRCX Lam Research
$366.51 /

+2.66 (+0.73%)

LRCX Lam Research
$366.51 /

+2.66 (+0.73%)

06:54 Today Mizuho
Lam Research price target raised to $410 from $400 at Mizuho
06:47 Today RBC Capital
Lam Research price target raised to $420 from $400 at RBC Capital
09/25/20 Citi
KLA on top, Amkor at bottom of Citi's Semiconductor rankings
09/20/20 Stifel
Stifel more positive on Semi Cap Equipment, upgrades Lam to Buy
SMICY SMIC
$5.41 /

+ (+0.00%)

09/07/20 Goldman Sachs
SMIC downgraded to Buy from Conviction Buy at Goldman Sachs
08/10/20 HSBC
SMIC downgraded to Reduce from Hold at HSBC
05/18/20 CIMB
SMIC upgraded to Hold from Reduce at CIMB
05/14/20 Morgan Stanley
SMIC upgraded to Equal Weight from Underweight at Morgan Stanley
LRCX Lam Research
$366.51 /

+2.66 (+0.73%)

LRCX Lam Research
$366.51 /

+2.66 (+0.73%)

SMICY SMIC
$5.41 /

+ (+0.00%)

LRCX Lam Research
$366.51 /

+2.66 (+0.73%)

LRCX Lam Research
$366.51 /

+2.66 (+0.73%)

Earnings
Citrix raises FY20 EPS $5.89-$5.99 from $5.65-$5.85, consensus » 07:19
10/22/20
10/22
07:19
10/22/20
07:19
CTXS

Citrix

$136.50 /

-0.38 (-0.28%)

Raises FY20 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTXS Citrix
$136.50 /

-0.38 (-0.28%)

CTXS Citrix
$136.50 /

-0.38 (-0.28%)

10/13/20 UBS
Citrix initiated with a Neutral at UBS
07/31/20 Stifel
Citrix disclosure points to $1B commitment, most likely to Azure, says Stifel
07/20/20
Fly Intel: Top five analyst upgrades
07/20/20 Barclays
Citrix upgraded to Overweight with $180 price target at Barclays
CTXS Citrix
$136.50 /

-0.38 (-0.28%)

CTXS Citrix
$136.50 /

-0.38 (-0.28%)

CTXS Citrix
$136.50 /

-0.38 (-0.28%)

Hot Stocks
Adicet Bio announces FDA clearance of IND application for ADI-001 » 07:18
10/22/20
10/22
07:18
10/22/20
07:18
ACET

Adicet Bio

$13.11 /

+0.15 (+1.16%)

Adicet Bio announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACET Adicet Bio
$13.11 /

+0.15 (+1.16%)

ACET Adicet Bio
$13.11 /

+0.15 (+1.16%)

10/16/20 Wedbush
Adicet Bio initiated with an Outperform at Wedbush
10/15/20 Wedbush
Adicet Bio initiated with an Outperform at Wedbush
  • 24
    Sep
ACET Adicet Bio
$13.11 /

+0.15 (+1.16%)

Recommendations
Abbott price target lowered to $118 from $136 at Credit Suisse » 07:18
10/22/20
10/22
07:18
10/22/20
07:18
ABT

Abbott

$105.87 /

-2.53 (-2.33%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABT Abbott
$105.87 /

-2.53 (-2.33%)

ABT Abbott
$105.87 /

-2.53 (-2.33%)

10/16/20 Citi
Citi opens 'positive catalyst watch' on DexCom
10/09/20 JPMorgan
Abbott price target raised to $125 from $110 at JPMorgan
10/07/20 Wells Fargo
Abbott price target raised to $122 from $120 at Wells Fargo
10/06/20 Canaccord
Quanterix price target raised to $40 from $38 at Canaccord
ABT Abbott
$105.87 /

-2.53 (-2.33%)

ABT Abbott
$105.87 /

-2.53 (-2.33%)

ABT Abbott
$105.87 /

-2.53 (-2.33%)

ABT Abbott
$105.87 /

-2.53 (-2.33%)

Hot Stocks
Gan Limited launches Play Agua social casino site, app » 07:17
10/22/20
10/22
07:17
10/22/20
07:17
GAN

Gan Limited

$15.40 /

+ (+0.00%)

Gan Limited announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GAN Gan Limited
$15.40 /

+ (+0.00%)

GAN Gan Limited
$15.40 /

+ (+0.00%)

10/15/20 Craig-Hallum
Strong results in NJ to encourage states to legalize iGaming, says Craig-Hallum
10/06/20 B. Riley Securities
Gan Limited shares have more room to run, says B. Riley Securities
08/21/20 B. Riley FBR
Gan selloff on FanDuel loss an overreaction, says B. Riley FBR
08/21/20 Craig-Hallum
Craig-Hallum says FanDuel migration a 'temporary blip' for Gan Limited
GAN Gan Limited
$15.40 /

+ (+0.00%)

  • 05
    May
GAN Gan Limited
$15.40 /

+ (+0.00%)

GAN Gan Limited
$15.40 /

+ (+0.00%)

GAN Gan Limited
$15.40 /

+ (+0.00%)

Earnings
Sandy Spring Bancorp reports Q3 EPS (94c), consenus (71c) » 07:17
10/22/20
10/22
07:17
10/22/20
07:17
SASR

Sandy Spring Bancorp

$25.51 /

+0.34 (+1.35%)

At September 30, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SASR Sandy Spring Bancorp
$25.51 /

+0.34 (+1.35%)

SASR Sandy Spring Bancorp
$25.51 /

+0.34 (+1.35%)

08/03/20 Piper Sandler
Sandy Spring Bancorp resumed with a Neutral at Piper Sandler
06/30/20 Stephens
Sandy Spring Bancorp resumed with an Equal Weight at Stephens
04/01/20 Keefe Bruyette
Sandy Spring Bancorp upgraded to Outperform from Market Perform at Keefe Bruyette
SASR Sandy Spring Bancorp
$25.51 /

+0.34 (+1.35%)

Recommendations
Tesla 'cleared the bar' on Q3 EPS, says Credit Suisse » 07:16
10/22/20
10/22
07:16
10/22/20
07:16
TSLA

Tesla

$422.56 /

+0.59 (+0.14%)

Credit Suisse analyst Dan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$422.56 /

+0.59 (+0.14%)

TSLA Tesla
$422.56 /

+0.59 (+0.14%)

06:37 Today Baird
Baird upgrades 'must own' Tesla to Outperform after earnings
06:36 Today Citi
Tesla quarter shows improved margin execution, says Citi
06:34 Today Baird
Tesla competitive moat growing, Baird upgrades to Outperform
06:24 Today Piper Sandler
Tesla keeps 'must-own' status after 'solid' Q3, says Piper Sandler
TSLA Tesla
$422.56 /

+0.59 (+0.14%)

  • 14
    Feb
TSLA Tesla
$422.56 /

+0.59 (+0.14%)

TSLA Tesla
$422.56 /

+0.59 (+0.14%)

TSLA Tesla
$422.56 /

+0.59 (+0.14%)

Recommendations
Teradyne price target raised to $110 from $95 at Deutsche Bank » 07:15
10/22/20
10/22
07:15
10/22/20
07:15
TER

Teradyne

$92.06 /

+4.09 (+4.65%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TER Teradyne
$92.06 /

+4.09 (+4.65%)

TER Teradyne
$92.06 /

+4.09 (+4.65%)

06:52 Today Baird
Teradyne price target raised to $105 from $90 at Baird
05:25 Today Susquehanna
Teradyne upgraded to Neutral from Negative at Susquehanna
10/09/20 Stifel
Teradyne upgraded to Buy on improving growth prospects at Stifel
10/09/20 Stifel
Teradyne upgraded to Buy from Hold at Stifel
TER Teradyne
$92.06 /

+4.09 (+4.65%)

TER Teradyne
$92.06 /

+4.09 (+4.65%)

TER Teradyne
$92.06 /

+4.09 (+4.65%)

Recommendations
Xilinx price target raised to $115 from $100 at Deutsche Bank » 07:15
10/22/20
10/22
07:15
10/22/20
07:15
XLNX

Xilinx

$111.36 /

-3.56 (-3.10%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLNX Xilinx
$111.36 /

-3.56 (-3.10%)

XLNX Xilinx
$111.36 /

-3.56 (-3.10%)

06:44 Today Morgan Stanley
Xilinx price target raised to $137 from $117 at Morgan Stanley
06:07 Today Goldman Sachs
Xilinx downgraded to Neutral from Conviction Buy at Goldman Sachs
10/20/20 Citi
Citi opens 'negative catalyst watch' on Xilinx, sees no AMD deal
10/16/20 RBC Capital
Xilinx price target raised to $92 from $84 at RBC Capital
XLNX Xilinx
$111.36 /

-3.56 (-3.10%)

XLNX Xilinx
$111.36 /

-3.56 (-3.10%)

XLNX Xilinx
$111.36 /

-3.56 (-3.10%)

XLNX Xilinx
$111.36 /

-3.56 (-3.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.